Total raised
$2.5M
Last: SAFE 2023-03
Stage
Seed
Founded
2018
Headcount
7
HQ
Haifa
Sector
Health Tech & Life Sciences
About
OpenDNA is developing an AI platform that combines clinical and genomic data analysis for polygenic diseases. The platform allows healthcare providers and payers to easily apply genomic precision medicine and population genomics approaches. Its prediction models help identify high risk patients and their key (or targeted) prevention strategies. The company has already implemented its AI solutions for cardiometabolic syndrome, and in the future means to apply the technology to other complex polygenic disease states, such as cancer; chronic kidney failure; and autoimmune, neurological, and musculoskeletal diseases.
Funding history · 3 rounds · $2.5M total
2023-03
SAFE
$1.0M
2022-03
Equity crowdfunding
Undisclosed
2020-06
Seed
Undisclosed
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesDigital HealthcareMedical Decision Support
Technologies
BiologicalsGenesArtificial IntelligenceMachine Learning
Target customers
Healthcare & Life SciencesHealthcareProvidersInsurance Companies
Business model
B2B
Highlights
1 PatentsVerified
Tags
blood-pressurechronic-diseasehealthcare-providerscardiovasculardigital-healthcareartificial-intelligencepatientsheart-diseasespersonalized-medicinemhealthdiabetesgeneticsheart-failure